九游会j9网站首页,j9九游会首页登录,j9九游会ag真人官网

    您好,欢迎光临九游会j9网站首页商城!
    服务热线:400 680 0892
    新闻资讯 News

    ROS-ID®缺氧/氧化应激检测试剂盒——ENZO热销产品

    2023-10-23
    浏览次数: 203

    Enzo Life SciencesROS-ID®Hypoxia/Oxidative stress detection kit专门用于使用荧光显微镜或流式细胞对活细胞(悬浮和贴壁)中的缺氧和氧化应激水平进行功能性检测。该试剂盒包含能够检测缺氧状态(红色)和氧化应激水平(绿色)的荧光探针。

    检测缺氧的染料(红色)利用缺氧细胞中存在的硝基还原酶活性,将硝基基团转化为羟胺(NHOH)和氨基(NH2)并释放出荧光探针。


    氧化应激检测试剂(绿色)是一种非荧光的、可透过细胞的总ROS检测染料,可与多种活性物质直接反应。可使用配备标准荧光素(490/525 nm)和德克萨斯红(596/670 nm)滤光片的宽场荧光显微镜、共聚焦显微镜或配备蓝色(488 nm)激光的流式细胞仪进行细胞分析。

     

    产品特点

    ● 高灵敏度和特异性的荧光探针,可用于检测活细胞的缺氧和氧化应激

    ● 可用于分析贴壁或悬浮细胞系

    ● 试剂盒内包含整套试剂,包括ROS和缺氧诱导剂

     

     

    实验示例

    ROS-ID®缺氧/氧化应激检测试剂盒——ENZO热销产品

    图1. 检测人HeLa和HL-60细胞中的缺氧和氧化应激水平。用缺氧诱导剂(DFO)和ROS诱导剂(pyocyanin)处理细胞。每个象限的数字反映了细胞(群体)的百分比。结果表明,缺氧和氧化应激染料具有特异性。

     

    ROS-ID®缺氧/氧化应激检测试剂盒——ENZO热销产品

    图2.使用不同试剂诱导HeLa细胞发生缺氧和氧化应激反应。缺氧探针在缺氧条件下被细胞硝基还原酶转化后观察到红色荧光。

     

    ROS-ID®缺氧/氧化应激检测试剂盒——ENZO热销产品

    图3.氧化应激(A)和缺氧(B)检测染料的吸收峰和发射峰分别为504nm/524nm和580nm/595nm。这些染料可以用488nm的氩离子激光器激发,并在流式细胞仪上的FL1通道(氧化应激染料)和FL3通道(缺氧红染料)中检测。

     

    产品信息

    产品货号

    ENZ-51042-0125/ ENZ-51042-K500

    产品名称

    ROS-ID® Hypoxia/Oxidative stress detection kit

    别名

    ROS / Nitroreductrase

    规格

    1*125tests/1*500tests

    短期保存

    -20°C

    长期保存

    -20°C

    试剂盒组分

    Hypoxia Red Detection Reagent

    Oxidative Stress Detection Reagent (Green)

    ROS Inducer (Pyocyanin)

    Hypoxia Inducer (DFO)

    应用

    Flow Cytometry, Fluorescence microscopy, Fluorescent detection, HTS

      

    部分产品引用文献

    1. Dimethyloxalylglycine (DMOG), a Hypoxia Mimetic Agent, Does Not Replicate a Rat Pheochromocytoma (PC12) Cell Biological Response to Reduced Oxygen Culture: R. Chen, et al.; Biomolecules 12, 541 (2022)

    2. Hydrogel microcapsules containing engineered bacteria for sustained production and release of protein drugs: C. Han, et al.; Biomaterials 287, 121619 (2022)

    3. Inhibiting autophagy flux and DNA repair of tumor cells to boost radiotherapy of orthotopic glioblastoma: Q. Xu, et al.; Biomaterials 280, 121287 (2022)

    4. Intracellular glucose starvation affects gingival homeostasis and autophagy: R. Li, et al.; Sci. Rep. 12, 1230 (2022)

    5. Intrinsic radical species scavenging activities of tea polyphenols nanoparticles block pyroptosis in endotoxin-induced sepsis: Y. Chen, et al.; ACS Nano 16, 2429 (2022)

    6. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy: Y. Dong, et al.; Drug Deliv. 29, 238 (2022)

    7. Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration delivery for enhanced photo-gene therapy towards glioma: R. Wang, et al.; Bioact. Mater. 13, 286 (2022)

    8. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework: W.L. Pan ,et al.; Biomaterials 283, 121559 (2022)

    9. Mitochondrial glutathione depletion nanoshuttles for oxygen-irrelevant free radicals generation: A cascaded hierarchical targeting and theranostic strategy against hypoxic tumor: B. Liang, et al.; ACS Appl. Mater. Interfaces 14, 13038 (2022)

    10. Multifunctional Nanosnowflakes for T1-T2 Double-Contrast Enhanced MRI and PAI Guided Oxygen Self-Supplementing Effective Anti-Tumor Therapy: Y. Lv, et al.; Int. J. Nanomedicine 17, 4619 (2022)

    11. Physiologic flow-conditioning limits vascular dysfunction in engineered human capillaries: K. Haase, et al.; Biomaterials 280, 121248 (2022)

    12. Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy: W. Jiang, et al.; J. Nanobiotechnology 20, 129 (2022)

    13. Strategy for improving cell-mediated vascularized soft tissue formation in a hydrogen peroxide-triggered chemically-crosslinked hydrogel: S.Y. Wei, et al.; J. Tissue. Eng. 13, 20417314221084096 (2022)

    14. A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances: P. Liu, et al.; J. Nanobiotechnology 19, 149 (2021)

    15. An albumin-based therapeutic nanosystem for photosensitizer/protein co-delivery to realize synergistic cancer therapy: S.L. Ai, et al.; ACS Appl. Bio. Mater. 4, 4946 (2021)

     


    Epicypher热销产品——CUTANA™ pAG-Tn5 for CUT&Tag

    详情请咨询Enzo Life Sciences金牌代理——欣博盛生物

    全国服务热线: 4006-800-892       邮箱: market@qckc0531.com 

    深圳: 0755-26755892         北京: 010-88594029            

    广州:020-87615159           上海: 021-34613729

    代理品牌网站: www.qckc0531.com 

    自主品牌网站: www.neobiosescience.net

    分享到:
    关注欣博盛公众号
    Copyright ©2021 - 2023 深圳九游会j9网站首页有限公司
      网站地图
    犀牛云提供企业云服务
    九游会j9网站首页